top of page
Human large intestine tissue under microscope view. Histological for human physiology..jpg

IntestInal PermeabilIty

The intestinal lining is made up of a single layer of cells called epithelial cells, These cells are tightly glued together by structures known as tight junctions, such as, ZO-1, claudins and occludin. These tight junctions are major components of the epithelial barrier, forming a seal between cells and controlling what passes through the gut lining into the body.

 

Directly beneath the intestinal lining is the basement membrane. The basement membrane is essentially ‘glued’ with a protein called laminin to the digestive epithelial cells. The membrane's primary role is to anchor down and provide structural support, as well as regulate epithelial cell proliferation, survival and differentiation, and acts as an additional barrier against passageways between cells. 

 

The basement membrane is made up of collagen and special sugar chains known as glycosaminoglycans (GAGs), such as heparan or chondroitin sulfate. GAGs require scaffolding to hold them in ways of forming supportive structure, and this is achieved by the help of proteins known as Proteoglycans, primarily Perlecan.

 

However, inflammation caused by dysbiosis, food sensitivities, chronic infection or immune overactivity can damage this system. Immune signals like TNF-alpha can trigger enzymes such as matrix metalloproteinases, which break down the collagen, laminin and pelicans in this matrix. Ultimately this weakens the gut barrier and increases permeability.

 

Furthermore modulators, such as Zonulin which effectively opens the junction gateways, can also become over-stimulated. This occurs with factors such as dietary choices and dysbiosis.

 

It is important to understand we all need a baseline level of intestinal permeability, it is part of normal intestinal physiology and designed for selective permeability. The issue when discussing “intestinal permeability” is in reference to non-selective permeability, allowing a host of microorganisms, food particles and endotoxins to enter systemic circulation when they shouldn't, causing detrimental effects [1],[2],[3],[4]

Signs & Symptoms

Skin Conditions
 

  • Acne

  • Dermatitis 

  • Eczema

  • Psoriasis

  • Candidiasis 

  • Acne

  • Folliculitis

  • Abscess and Boils

  • Hives

  • Skin Itching


Skin conditions have a direct association with the gut and increased intestinal permeability. This is because the translocation of microbial metabolites, endotoxins, and immune triggers pass through the gut barrier into systemic circulation. This process drives chronic low-grade inflammation and various kinds of immune dysregulation, which research has clearly demonstrated underpins the pathogenesis of many inflammatory skin disorders. Clinically proven examples include:
 

  • Dermatitis and Eczema, linked to impaired gut barrier function allowing antigen leakage and Th2-dominant immune activation, paralleling skin barrier dysfunction.
     

  • Psoriasis, permeability lead to translocation of bacterial DNA (e.g., E. coli) and endotoxins that trigger systemic inflammation via IL-17, IL-23, and TNF-α pathways, promoting keratinocyte proliferation.
     

  • Acne and rosacea, microbial by-products and neuroendocrine alterations, such as serotonin, mTORC1 signalling, which is linked to gut barrier breakdown are connected to sebaceous and vascular inflammation.
     

  • Abscess and boils, reduced microbial diversity and barrier dysfunction increase circulating inflammatory mediators that worsen follicular occlusion and abscess formation.
     

  • Hives and Seborrheic dermatitis, systemic inflammatory mediators arising from barrier compromise influence mast-cell activity and skin lipid metabolism.
     

  • Candida, actively causes intestinal permeability by releasing enzymes and toxins aspartyl proteases and phospholipases, which damage epithelial cells and allow fungal fragments to leak into circulation. [48][49][50][51]


IgE - Food Allergies, Immediate Hypersensitivity
 
Several studies show that when the intestinal barrier is compromised and permeable, food-derived proteins cross into the circulation more readily. When this takes place, these food proteins are taken up by antigen-presenting cells. This process promotes food-specific immune mediated IgE production, which initiates the sensitization of mast cells.
 
Therefore when the same food is consumed again in future and the food protein permeates into the blood stream, it can attach to the precreated IgE antibodies on mast cells, which then causes them to release histamine, typically within 30 minutes of consuming the food.
 
IgE Mediated reactions are most commonly associated with:

  • Facial flushing

  • Eczema

  • Dermatitis 

  • Skin itching

  • Peeling Nail Beds

  • Keratiderma - Thickened skin on the heels 

  • Nasal congestion

  • Coughing and Sneezing

  • Asthma

  • Headaches

  • Brain fog

  • Irritability and Anxiety


Certain foods are more likely to trigger these reactions because their proteins resist gastric acid, heat, and enzymatic digestion, leaving larger fragments that increase immune exposure and reaction, particularly if barrier function is impaired allowing more into systemic circulation. 
 
Common food triggers include:
 

  • Cow’s milk

  • Wheat

  • Yeast - including beer

  • Eggs

  • Peas

  • Peanuts and other nuts

  • Soy

  • Corn

  • Fish

  • Shellfish - shrimp, crab, lobster, squid

  • Sesame
     

[9],[10],[11],[12],[33],[34][43][44]
 
IgG - Food Intolerances, Delayed Hypersensitivity
 
Beyond IgE immune reactions, enhanced translocation of food-derived proteins can also stimulate IgG immune responses. IgG reactions are not mediated by mast cells, rather IgG complexes activate the release of pro-inflammatory cytokines, including TNF-α, IL-6, IL-1. This results in a delayed, low-grade systemic inflammation, occurring anywhere between 4 - 48 hours after food exposure, and commonly affects the gut, joints, skin, and nervous system. [34]
 
IgG Mediated reactions are most commonly associated with:
 

  • Eczema 

  • Psorasis 

  • Irritable Bowel Syndrome (IBS)

  • Abdominal cramps

  • Diarrhoea or Constipation

  • Headaches + Migraines [39][40][41][42]

 
 Common trigger foods include:
 

  • Cow’s milk

  • Wheat

  • Yeast - including beer

  • Eggs

  • Peas

  • Peanuts and other nuts

  • Soy

  • Corn

  • Fish

  • Shellfish - shrimp, crab, lobster, squid

  • Sesame
     

[9],[10],[11],[12],[33],[34][43]

Autoimmunty 
 
Autoimmunity is increasingly recognized as being closely linked to intestinal permeability. When the intestinal barrier is compromised, it loses its ability to selectively regulate what enters the bloodstream, allowing food-derived proteins, and bacterial components such as lipopolysaccharide (LPS) to cross into systemic circulation. 
 
These are then processed by antigen-presenting cells, driving activation of Th1 and Th17 immune pathways, secretion of pro-inflammatory cytokines, including TNF-α, IL-1, IL-6, which in a cascade of events encourages the loss of the body’s ability to recognize its own tissues as safe
 
This process can be intensified by molecular mimicry, where bacterial components or food-derived protein fragments closely resemble the body’s own tissue proteins. Because of this similarity, the immune system may mistakenly produce cross-reactive autoantibodies that not only target the foreign substances but also attack the body’s own tissues, encouraging the process of autoimmunity.
 
This has been demonstrated in various studies, including a large study including only participants with high zonulin levels, which is a marker of intestinal hyper-permeability. These subjects were tested for a spectrum of autoantibodies linked to different autoimmune diseases. The results showed that those with markers of increased permeability had a significantly higher likelihood of carrying autoantibodies associated with various autoimmune conditions. These results were then interpreted as showing the increased likelihood of having or developing autoimmune activity associated with intestinal permeability. [37] Results are detailed below.  
 

  • Rheumatoid and Arthritic disease, 30× more likely

  • Addison’s disease, 28× more likely

  • Sjogren's Syndrome, 26 x more likely 

  • Autoimmune hepatitis, 22× more likely

  • Cerebellar autoimmunity, 22× more likely

  • Cardiac autoimmunity, 10× more likely

  • Type 1 diabetes, 10× more likely

  • Neurologic autoimmunity, 8.7× more likely

  • Inflammatory bowel disease, including Crohn’s and UC, 8.4× more likely

  • Joint + Connective tissue autoimmunity, 7.2× more likely

  • Ovarian or Testicular failure, 7.1× more likely

  • IBD spectrum, 7.0× more likely

  • Multiple sclerosis, 6.9× more likely

  • Autoimmune gastritis, 5.8× more likely

  • Graves Disease, up to 8x increase in disease severity

  • Hashimoto’s thyroiditis, 2.4× more likely, further notes below

  • Vitiligo, Higher in IP, association found, probability unknown

  • Ankylosing Spondylitis, association found, probability unknown

  • Alopecia Areata, association found, probability unknown

  • Systemic Lupus, 53% correlation between permeability and disease activity

 
Whilst the above study demonstrated a reduced implication of intestinal permeability on Hashimoto's Thyroiditis, multiple other studies signify there is a much stronger correlation, with one study on 40 participants with Hashimoto's indicating that 62% of the participants had biomarkers that indicated intestinal permeability [35][36][38][52][53][54][55][56][57]
 
Inflammatory Digestive Disorders + Diseases
 
The following digestive disorders and diseases have been clinically demonstrated to exhibit increased intestinal permeability, a feature that persists even during states of remission. Further details listed in Causes.
 

  • Ulcerative Colitis 

  • Microscopic Colitis

  • Chron’s Disease

  • Celiac Disease

  • Diverticulitis 

  • Non Celiac Wheat or Gluten Sensitivity [45][46]


Diarrhoea 
 
Diarrhea-predominant IBS is frequently linked with increased intestinal permeability. Across multiple human studies using standard permeability probes, a substantial subset of IBS-D patients demonstrate barrier dysfunction and permeability, which often tracks with diarrhea severity and abdominal pain. Clinical data from the systematic reviews on 13 studies demonstrated a prevalence of increased permeability in Diarrhoea prominent IBS cases in between 37 - 62% of participants. [47]
 
Asthma
 
When the intestinal barrier is compromised, it loses its ability to selectively regulate what enters the bloodstream, and bacterial components such as lipopolysaccharide (LPS) cross into systemic circulation. 
 
Lipopolysaccharides engage with Toll-like receptor 4 on airway epithelial cells, alveolar macrophages, and dendritic cells, triggering amplified release of pro-inflammatory cytokines. This promotes a signalling cascade, which intensifies local airway hyper-responsiveness, characterised by increased bronchoconstriction, mucus hyper-secretion, and airway edema. Consequently, individuals with chronic LPS translocation are predisposed to greater asthma severity, persistent wheeze, and heightened allergic airway inflammation. [34]
 
Acne 
 
Research has demonstrated that acne has a close connection with the gastrointestinal tract and that alterations in the gut microbiota increase intestinal permeability, allowing bacterial metabolites and endotoxins to enter systemic circulation.  This altercation disturbs the skin equilibrium as it triggers the release of pro-inflammatory cytokines, which circulate throughout the body and reach the skin’s sebaceous glands. These cytokines then stimulate immune activity within the skin, leading to increased sebum production, follicular blockage, and inflammation, which are key processes in the development of acne. [48]

Chronic Low Energy
 
Increased intestinal permeability, allows harmful substances like bacterial toxins such as lipopolysaccharide (LPS) to leak from the gut into the bloodstream. This process triggers an immune response that can contribute to the production of pro-inflammatory cytokines. These cytokines then signal to the central nervous system, producing ‘sickness behavoir’, characterised by fatigue.
 
At the cellular level, chronic LPS exposure also impairs mitochondrial function, disrupting electron transport and reducing ATP availability. The combination of neuroimmune signaling and impaired energy production explains why systemic LPS is strongly associated with low energy and persistent fatigue. [5][34]

Causes

Chronic Stress [ SNS Hyperactivity ]

 

When the nervous system is out of balance, such as in periods of chronic stress, the sympathetic "fight or flight" system is overactive and the parasympathetic "rest and digest" system is underactive, which subsequently decreases vagal activity.

 

Chronic stress prolongs this imbalance, reducing signals sent through the vagus nerve both to and from the brain. As a result, key anti-inflammatory responses like the cholinergic anti-inflammatory pathway (CAP) and the vagal-sympathetic pathway (VSP) are weakened. This leads to an increase in pro-inflammatory chemicals, such as TNF-alpha and IL-6. If this inflammation is not properly controlled, it disrupts the tight junctions between gut lining cells, causing intestinal permeability [13]. 

 

Inflammatory Bowel Disease

 

  • Ulcerative Colitis 

  • Chron’s Disease

 

In clinical research, Lactulose, which is a type of sugar that is too large to be absorbed easily by a healthy gut, is used to measure intestinal permeability in patients with inflammatory bowel disease. Researchers assessed the level of Laculose found in the samples of healthy individuals vs those with intestinal permeability, the results demonstrated the following:

 

  • Healthy individuals: Average 1.8 mg Lactulose, which is used as a baseline

  • IBD in remission: Average 3.6 mg lactulose in urine, double the permeability

  • IBD active disease: Average 3.5 mg lactulose [45]

 

Notably, increased intestinal permeability is evident during active flares of inflammatory bowel disease, yet remains at a similar level even when the disease is in endoscopic remission.

 

Celiac Disease 

 

In celiac disease, gluten triggers an immune response that damages the small intestine lining. A key part of this process is increased intestinal permeability. Even on a gluten-free diet, barrier function often only partly recovers, meaning many patients retain some degree of permeability compared with healthy people.

 

In clinical trials increases in permeability markers such as Lactulose, and barrier functioning, compared with healthy controls are demonstrated as the following:

 

  • 5 - 13 times higher permeability than healthy Individuals

  • 50 - 56% lower resistance. Barrier functioning at half the strength of a healthy gut.

  • Gluten-free diet improves, but barrier function remains 25% weaker compared to healthy individuals. [46]
     

Non-Celiac, Gluten or Wheat Sensitivity 

 

Some individuals develop gut and sometimes whole-body symptoms after eating gluten or wheat, but without the autoimmune damage seen in celiac disease. Research shows that these individuals can still have barrier dysfunction, although unlike celiac disease, this does not usually involve major tissue destruction, but it still represents a barrier problem.

 

A clinical study demonstrated the following increases in permeability markers compared with healthy controls:

 

  • Utilising Confocal endomicroscopy, within minutes of wheat exposure, patients showed visible epithelial leaks and gaps, absent in healthy controls.

  • Biopsies to individuals wheat sensitive often show increased claudin-2, which makes the barrier more permeable.

  • Tissue samples from gluten-sensitive individuals demonstrate barrier impairment similar to active celiac patients when exposed to gluten proteins

Dysbiosis 

 

Dysbiosis classified as an imbalance of pathogenic to beneficial bacteria is a contributing factor to increased GI permeability. This is because bacteria such as E.Coli, Salmonella and Clostridium have been found to trigger the release of zonulin, which loosens the tight junctions between intestinal cells [15].

 

Poor Sugar Metabolism [ Impaired Glucose Tolerance ] 

 

In conditions like Impaired Glucose Tolerance and being overweight  IL-6 levels are found to be higher in the bloodstream and tissues. IL-6 activates certain genes that are linked to zonulin production. This ultimately leads to an increased permeability of the gut, allowing substances that are normally kept out to enter the bloodstream [14].

 

Food Sensitivities

 

When the immune system encounters a food that it's sensitive to, it produces IgG antibodies against that food. This is often a delayed response, so symptoms may take hours or even days to appear.

 

In instances of IgG-mediated food sensitivities, specifically to foods like wheat, dairy, and eggs there are higher levels of anti-LPS and anti-occludin antibodies, depending on the severity of the immune response. High levels of anti-LPS and anti-occludin trigger a cascade of pro-inflammatory cytokines such as TNF-alpha, which then contribute to GI permeability [16].

 

Gastrointestinal Infections

 

  • SIBO

  • Candidais 

  • Helminths - Worms

  • Protozoa Infections - Parasites

 

Acute inflammation or infection results in the induction of mucin synthesis and secretion by the goblet cells, preventing pathogen contact. Although states of chronic inflammation and infection caused by conditions such as SIBO, Candidiasis, Helminths and Protozoa result in the depletion of goblet cells, which leads to defective mucin synthesis and poor mucus integrity. If this mucus layer is thin, patchy, or degraded, microbes and toxins can directly contact the epithelial cells, eliciting cytokines like TNF-alpha, IL-6, which loosen the junctions and lead to gut permeability [13].
 

Alcoholism 

 

Chronic alcohol use can promote the growth of gram-negative bacteria in the intestine which leads to the accumulation of endotoxins and inflammation. In addition, alcohol metabolism by gram-negative bacteria and the intestinal epithelial cells, leads to the accumulation of acetylaldehyde which disrupts the tight junctions leading to increased intestinal permeability [18].

 

Protein deficiency

 

Although the gastrointestinal tract represents only 4-6% of total body mass, the intestines are a major site for amino acid utilisation and metabolism, accounting for 25-50% of whole protein turnover.

 

Amino acids taken up by the intestine can be utilised to support intestinal mucosa integrity and function by:

 

• Providing fuel to enterocytes for metabolic processes such as active nutrient transport

• Providing essential amino acids for polyamine synthesis, which are then involved in cellular proliferation, repair, and differentiation 

• Providing amino acids for incorporation in secretory proteins (mucin), supporting the intestinal mucosa for epithelial protection [19]

 

Medications

 

Chronic use of anti-inflammatories such as ibuprofen and aspirin can cause gastrointestinal complications including erosion of the mucosa. This is thought to be due to their ability to inhibit glucosamine synthetase, an enzyme involved in the production of N-acetyl glucosamine which may subsequently lead to decreased GAG synthesis, and subsequently a breakdown of the GI scaffolding [19]. 

 

Chemotherapy and radiotherapy induced intestinal damage 

 

Gastrointestinal mucosal toxicity is a common side effect of chemotherapy or radiotherapy which increases susceptibility to injury and permeability [19].

References

 

[1].https://www.biomedica.com.au/media/contentmanager/content/Gastrointestinal_Tissue_Integrity.pdf

[2].https://www.thelancet.com/journals/langas/article/PIIS2468-1253%2824%2900390-X/fulltext?

[3] https://pubmed.ncbi.nlm.nih.gov/18485912/

[4] https://pubmed.ncbi.nlm.nih.gov/36147305/

[5].https://pmc.ncbi.nlm.nih.gov/articles/PMC2964729/#:~:text=The%20frequent%20association%20between%20CFS,of%20aerobic%20bacteria%20%5B18%5D.

[6] https://www.sciencedirect.com/science/article/abs/pii/S0166432823001778?via%3Dihub

[7] https://pmc.ncbi.nlm.nih.gov/articles/PMC6587489/

[8] https://pmc.ncbi.nlm.nih.gov/articles/PMC8177645/

[9] https://pubmed.ncbi.nlm.nih.gov/34465387/

[10] https://pmc.ncbi.nlm.nih.gov/articles/PMC10987687/

[11] https://www.sciencedirect.com/science/article/abs/pii/S0165587625001375

[12] https://pmc.ncbi.nlm.nih.gov/articles/PMC8949204/

[13].https://www.metagenicsinstitute.com.au/tech-data/boswellia-and-coptis-for-gut-and-systemic-inflammation

[14] https://pmc.ncbi.nlm.nih.gov/articles/PMC3458511/

[15] https://pmc.ncbi.nlm.nih.gov/articles/PMC3458511/

[16] https://pubmed.ncbi.nlm.nih.gov/36147305/

[17].https://www.mdpi.com/2036-7422/15/1/13#:~:text=Among%20the%20IBD%20patients%2C%20zonulin,the%20number%20of%20CD19%2B%20cells.

[18].https://pmc.ncbi.nlm.nih.gov/articles/PMC2614138/#:~:text=Alcohol%20exposure%20can%20promote%20the%20growth%20of,of%20tight%20junction%20and%20adherens%20junction%20proteins.

[19].https://www.biomedica.com.au/media/contentmanager/content/Gastrointestinal_Tissue_Integrity.pdf

[20] https://pubmed.ncbi.nlm.nih.gov/18485912/
[21].https://assets.contentstack.io/v3/assets/bltaf9269dac47f331a/blt77e65e5bd4cea986/66bc64647cb3ffcecd23bb61/Saccharomyces_boulardii.pdf

[22] https://pmc.ncbi.nlm.nih.gov/articles/PMC11172644/

[23].https://www.metagenicsinstitute.com.au/tech-data/glutamine-boswellia-bospure-intestinal

[24] https://academic.oup.com/ecco-jcc/article/18/10/1672/7673983#google_vignette

[25] https://www.lifestylematrix.com/blog/post/polyphenols-the-new-prebiotic-frontier

[26] https://pubmed.ncbi.nlm.nih.gov/19297429/

[27] https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.610164/full

[28] https://pubmed.ncbi.nlm.nih.gov/34573017/

[29] https://www.metagenicsinstitute.com.au/tech-data/glutamine-boswellia-bospure-intestinal

[30] https://pmc.ncbi.nlm.nih.gov/articles/PMC9028931/

[31].https://pubmed.ncbi.nlm.nih.gov/35659631/#:~:text=Abstract,use%20to%20gastroenterologists%20and%20endoscopists.

[32] https://pmc.ncbi.nlm.nih.gov/articles/PMC4604320/table/T2/

[33] https://pmc.ncbi.nlm.nih.gov/articles/PMC9101724/

[34] https://pmc.ncbi.nlm.nih.gov/articles/PMC7033038/

[35] https://pubmed.ncbi.nlm.nih.gov/33746942/

[36] https://www.sciencedirect.com/science/article/pii/S2666396124000396

[37] https://pmc.ncbi.nlm.nih.gov/articles/PMC10671756/

[38].https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.579140/full

[39].https://www.eurofins-biomnis.com/wp-content/uploads/2017/11/DS40-INTGB-Food_intolerances.pdf

[40] https://pmc.ncbi.nlm.nih.gov/articles/PMC6074204/

[41] https://pubmed.ncbi.nlm.nih.gov/29685016/

[42] https://pubmed.ncbi.nlm.nih.gov/1083739/
[43] https://pmc.ncbi.nlm.nih.gov/articles/PMC6074204/

[44] https://www.sciencedirect.com/science/article/pii/S0022202X18320426

[45].https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izaf043/8069436

[46] https://pmc.ncbi.nlm.nih.gov/articles/PMC6835310/

[47] https://pmc.ncbi.nlm.nih.gov/articles/PMC7925957/
[48] https://pmc.ncbi.nlm.nih.gov/articles/PMC6678709/

[49] https://pmc.ncbi.nlm.nih.gov/articles/PMC12476645/

[50] https://pubmed.ncbi.nlm.nih.gov/40681534/

[51].https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-023-01586-y

[52] https://pmc.ncbi.nlm.nih.gov/articles/PMC12054231/

[53].https://www.sciencedirect.com/science/article/abs/pii/S004901722100072X

[54] https://pubmed.ncbi.nlm.nih.gov/38460891/

[55] https://pubmed.ncbi.nlm.nih.gov/29808708/

[56] https://pmc.ncbi.nlm.nih.gov/articles/PMC7815467/

[57] https://pmc.ncbi.nlm.nih.gov/articles/PMC10724020/

bottom of page